|
|
Volumn 33, Issue SUPPL. 4, 1998, Pages 16-17
|
|
T1 and T2 bladder cancer: Selecting optimal therapy
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BCG VACCINE;
BLADDER CANCER;
CANCER GROWTH;
CANCER INVASION;
CANCER RECURRENCE;
CANCER STAGING;
CANCER SURVIVAL;
CONFERENCE PAPER;
CYSTECTOMY;
HUMAN;
IMMUNOTHERAPY;
INSTRUMENTATION;
METASTASIS;
PRIORITY JOURNAL;
PROGNOSIS;
QUALITY OF LIFE;
REOPERATION;
SURGICAL TECHNIQUE;
TRANSITIONAL CELL CARCINOMA;
TRANSURETHRAL RESECTION;
TREATMENT PLANNING;
URINARY DIVERSION;
|
|
EID: 0031972315
PISSN: 03022838
EISSN: None
Source Type: Journal
DOI: 10.1159/000052256 Document Type: Conference Paper |
|
Times cited : (2)
|
|
References (3)
|
